**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 569-61-9 |Pararosaniline Chloride | 0.2% | 209-321-2 |
|----------------|--------------------------------------|----------|-----------|
| 7647-01-0 |Hydrochloric Acid, .1M | Balance | 231-595-7 |
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: XN
Risk Phrases: 33
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Danger of cumulative effects.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May cause skin sensitization, an allergic
reaction, which becomes evident upon re-exposure to this material.
Ingestion:
May cause effects similar to those for inhalation exposure.
Inhalation:
May cause respiratory tract irritation. May cause methemoglobinemia,
cyanosis (bluish discoloration of skin due to deficient oxygenation
of the blood), convulsions, tachycardia, dyspnea (labored breathing),
and death. May cause anemia.
Chronic:
Possible cancer hazard based on tests with laboratory animals.
Chronic exposure can affect thyroid function. May cause pituitary
gland abnormalities.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Get medical aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
Absorption of this product into the body may cause cyanosis (bluish
discoloration of skin due to deficient oxygenation of the blood).
Moderate degrees of cyanosis need to be treated only by supportive
measures: bed rest and oxygen inhalation. For methemoglobinemia,
administer oxygen alone or with Methylene Blue depending on the
methemoglobin concentration in the blood. Cleansing of the entire
contaminated area of the body is of utmost importance.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Dusts at sufficient concentrations can form
explosive mixtures with air. Combustion generates toxic fumes.
Extinguishing Media:
Use carbon dioxide or dry chemical.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Sweep up or absorb material, then place into a suitable clean, dry,
closed container for disposal. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Minimize dust
generation and accumulation. May form flammable dust-air mixtures. Do
not get in eyes, on skin, or on clothing. Keep container tightly
closed. Do not ingest or inhale.
Storage:
Store in a cool, dry, well-ventilated area away from incompatible
substances. Keep containers tightly closed.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use process enclosure,
local exhaust ventilation, or other engineering controls to control
airborne levels.
Exposure Limits
CAS# 569-61-9:
CAS# 7647-01-0:
United Kingdom, WEL - TWA: 1 ppm TWA (aerosol mist and gas); 2 mg
TWA (aerosol mist and gas)
United Kingdom, WEL - STEL: 5 ppm STEL (aerosol mist and gas); 8
mg/m3 STEL (aerosol mist and gas)
United States OSHA: ; 5 ppm Ceiling; 7 mg/m3 Ceiling
Belgium - TWA: 5 ppm VLE; 8 mg/m3 VLE
Belgium - STEL: 10 ppm VLE; 15 mg/m3 VLE
France - VLE: 5 ppm VLE; 7.5 mg/m3 VLE
Germany: 8 mg/m3 TWA
Japan: 5 ppm Ceiling; 7.5 mg/m3 Ceiling
Malaysia: 5 ppm Ceiling; 7.5 mg/m3 Ceiling
Netherlands: 10 ppm STEL; 15 mg/m3 STEL
Netherlands: 5 ppm MAC; 8 mg/m3 MAC
Russia: 5 mg/m3 TWA
Spain: 5 ppm VLA-ED; 7.6 mg/m3 VLA-ED
Spain: 10 ppm VLA-EC; 15 mg/m3 VLA-EC
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: dark brown
Odor: None reported.
pH: Not available.
Vapor Pressure: Negligible.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: Not available.
Specific Gravity/Density: Not available.
Molecular Formula: C19H18ClN3
Molecular Weight: 323.82
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures. Decomposes when
heated.
Conditions to Avoid:
Incompatible materials, temperatures above 200C.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 569-61-9: CX9850100
CAS# 7647-01-0: MW4025000 MW4031000
LD50/LC50:
CAS# 569-61-9: Oral, mouse: LD50 = 5 gm/kg.
CAS# 7647-01-0: Inhalation, mouse: LC50 = 1108 ppm/1H; Inhalation,
mouse: LC50 = 20487 mg/m3/5M; Inhalation, mouse: LC50 = 3940
mg/m3/30M; Inhalation, mouse: LC50 = 8300 mg/m3/30M; Inhalation,
rat: LC50 = 3124 ppm/1H; Inhalation, rat: LC50 = 60938 mg/m3/5M;
Inhalation, rat: LC50 = 7004 mg/m3/30M; Inhalation, rat: LC50 =
45000 mg/m3/5M; Inhalation, rat: LC50 = 8300 mg/m3/30M; Oral,
rabbit: LD50 = 900 mg/kg.
Carcinogenicity:
Pararosaniline Chloride -
California: carcinogen, initial date 7/1/89
NTP: Suspect carcinogen
IARC: Group 2B carcinogen
Hydrochloric Acid, .1M -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
USA RQ: CAS# 7647-01-0: 5000 lb final RQ; 2270 kg final RQ
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 33 Danger of cumulative effects.
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 569-61-9: 3
CAS# 7647-01-0: 1
Canada
CAS# 569-61-9 is listed on Canada's DSL List.
CAS# 7647-01-0 is listed on Canada's DSL List.
CAS# 569-61-9 is listed on Canada's Ingredient Disclosure List.
CAS# 7647-01-0 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 569-61-9 is listed on the TSCA inventory.
CAS# 7647-01-0 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
R 36/37/38 Irritating to eyes, respiratory system and
skin.
MSDS Creation Date: 5/15/1998 Revision #4 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|